Patents by Inventor Tao Guo

Tao Guo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160086690
    Abstract: A cable beam is provided and includes a first cable and a second cable. The first cable includes a first conductor and a first PTC material layer clad on the first conductor. The second cable includes a second conductor and a second PTC material layer clad on the second conductor. The second cable is wound with the first cable and the first PTC material layer is electrically connected to the second PTC material layer.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 24, 2016
    Applicant: RAYCHEM ELECTRONICS (SHANGHAI) LTD.
    Inventors: Tao Guo, Wei Zhen, Jianyong Liu
  • Publication number: 20160086689
    Abstract: A cable is provided and includes a first conductor, a second conductor, and a PTC material layer. The PTC material layer is directly bonded to and electrically connects the first conductor and the second conductor.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 24, 2016
    Applicant: Raychem Electronics (Shanghai) Co., Ltd.
    Inventors: Tao Guo, Wei Zhen, Jianyong Liu
  • Patent number: 9287765
    Abstract: A power system, a power module therein and a method for fabricating power module are disclosed herein. The power module includes a first and a second common pins, and a first and a second bridge arms. The first and the second common pins are symmetrically disposed at one side of a substrate. The first bridge arm includes a first and a second semiconductor devices, and the first and the second semiconductor devices are connected to each other through the first common pin and disposed adjacently. The second bridge arm includes a third and a fourth semiconductor devices, and the third and the fourth semiconductor devices are connected to each other through the second common pin and disposed adjacently. The first and the third semiconductor devices are disposed symmetrically, and the second and the fourth semiconductor devices are disposed symmetrically.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: March 15, 2016
    Assignee: DELTA ELECTRONICS, INC.
    Inventors: Jian-Hong Zeng, Shou-Yu Hong, Xue-Tao Guo
  • Publication number: 20160056139
    Abstract: A circuit protection device is provided and includes a first insulation layer, a second insulation layer, a thermal fuse, a diode, a first exterior electrode pad, a second exterior electrode pad, and a third exterior electrode pad. The second insulation layer is positioned above a top surface of the first insulation layer. The thermal fuse is packaged in the first insulation layer and having a first electrode end and a second electrode end positioned opposite to the first electrode end. The diode is packaged in the second insulation layer and having a first electrode surface and a second electrode surface positioned opposite to the first electrode surface. The first exterior electrode pad is positioned on a bottom surface of the first insulation layer and electrically connected to the first electrode surface and the first electrode end.
    Type: Application
    Filed: August 25, 2015
    Publication date: February 25, 2016
    Applicant: Tyco Electronics (Shanghai) Co. Ltd.
    Inventors: Yan Fang, Bin Wang, Jianzhe Ye, Tao Guo, Jianyong Liu
  • Publication number: 20160049784
    Abstract: A circuit protection device that includes a PTC device and a diode is disclosed. A first insulation layer is formed between the first electrode surfaces of the diode and the PTC device. Vias for thermally and electrically connecting the first electrode surface of the diode and the first electrode surface of the PTC device are formed in the first insulation layer. First, second, and third external electrode pads are provided on the second insulation layer formed on the second electrode surface of the PTC device. The second electrode surface of the PTC device is electrically connected to the first external electrode pad. The first electrode surface of the diode and the first electrode surface of the PTC device are electrically connected to the second external electrode pad. The second electrode surface of the diode is electrically connected to the third external electrode pad.
    Type: Application
    Filed: August 12, 2015
    Publication date: February 18, 2016
    Applicant: Tyco Electronics (Shanghai) Co. Ltd.
    Inventors: Jianzhe Ye, Bin Wang, Hui Hu, Tao Guo, Jianyong Liu
  • Publication number: 20160024004
    Abstract: The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.
    Type: Application
    Filed: December 27, 2013
    Publication date: January 28, 2016
    Inventors: XIAODONG XU, JU-TAO GUO, TONG XIAO, YANMING DU, TIMOTHY BLOCK, SIMON DAVID PETER BAUGH, HONG YE
  • Patent number: 9243002
    Abstract: The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: January 26, 2016
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Xing Dai, Hong Liu, Anandan Palani, Shuwen He, Linda L. Brockunier, Ravi Nargund, Karen Marcantonio, Nicolas Zorn, Dong Xiao, Xuanjia Peng, Peng Li, Tao Guo
  • Publication number: 20150361101
    Abstract: The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
    Type: Application
    Filed: February 3, 2014
    Publication date: December 17, 2015
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Xing Dai, Hong Liu, Anandan Palani, Shuwen He, Linda L. Brockunier, Ravi Nargund, Karen Marcantonio, Nicolas Zorn, Dong Xiao, Xuanjia Peng, Peng Li, Tao Guo
  • Publication number: 20150358829
    Abstract: A wireless telecommunication system is described comprising a shared base station able to divide resources between multiple network operators sharing the base station. The base station resources are divided into resource pools having their own set of sharing rules and associated scheduling method that may be configured independently for each resource pool. A number of techniques are described that may be used to ensure flexibility and fairness of access to the base station resources for the multiple network operators.
    Type: Application
    Filed: April 4, 2014
    Publication date: December 10, 2015
    Applicant: NEC Corporation,
    Inventors: ROBERT ARNOTT, TAO GUO
  • Publication number: 20150351118
    Abstract: A wireless telecommunication system is described comprising a shared base station able to divide resources between multiple network operators sharing the base station. The base station resources are divided into sets of resources reserved for each network operator respectively and resources shared by all network operators. The shared base station is configured to monitor the usage of its resources by each operator and to determine, for each scheduling round, an appropriate prioritisation of communication bearers associated with the network operators.
    Type: Application
    Filed: January 24, 2014
    Publication date: December 3, 2015
    Applicant: NEC Corporation
    Inventors: Robert ARNOTT, Tao GUO
  • Patent number: 9200323
    Abstract: The present invention provides an improved nucleic acid hybridization process employing a modified oligonucleotide probe comprising naturally occurring nucleotide bases. At least one nucleotide in the modified oligonucleotide is artificially mismatched relative to the control nucleic acid in addition to any mismatches arising from a variant nucleic acid target containing a sequence variation. The artificial mismatch and the sequence variation positions are separated from one another on the oligonucleotide by six to nine nucleotide positions.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: December 1, 2015
    Assignees: CapitalBio Corporation, Tsinghua University
    Inventors: Huafang Gao, Ze Li, Dong Wang, Yanhua Liu, Xiang Liu, Yangzhou Jiang, Li Li, Chuanzan Zhao, Gengxin Lan, Tao Guo, Bin Cai, Jing Cheng
  • Publication number: 20150312444
    Abstract: The present disclosure relates to a method, a server and a terminal device for synchronizing a photograph. The method includes: sending an instruction for synchronizing a re-focusable photograph to a second terminal device; receiving a notification returned from the second terminal device with regard to whether the second terminal device supports a display of re-focusable photographs; sending data for downloading a re-focusable photograph group to the second terminal device, if the second terminal device supports the display of the re-focusable photographs; and sending an index photograph of the re-focusable photograph group to the second terminal device, if the second terminal device does not support the display of the re-focusable photographs. Through the solutions according to the present disclosure, network resources occupied by the synchronizing may be saved.
    Type: Application
    Filed: October 31, 2014
    Publication date: October 29, 2015
    Inventors: Jingwei Cai, Tao Guo, Hai Jiang
  • Publication number: 20150307443
    Abstract: Pharmaceutical compositions of the invention comprise functionalized benzamide derivatives useful as pregenomic RNA encapsidation inhibitors, and are useful for the treatment of Hepatitis B virus (HBV) infection.
    Type: Application
    Filed: December 5, 2013
    Publication date: October 29, 2015
    Inventors: XIAODONG XU, TIMOTHY M. BLOCK, JU-TAO GUO, YANMING DU
  • Patent number: 9168260
    Abstract: The present invention describes a unique antiviral screen system. The assay is based on quantitatively monitoring viral activation of host cell beta-interferon (IFN-?) gene expression in a HEK293-derived reporter cell line expressing a firefly luciferase gene under the control of a human IFN-? promoter. Unlike the traditional high throughput antiviral assays that measure either the reduction of viral components/yields or cytopathic effect, the readout of the reporter assay in the present invention is the virus-induced host cellular innate immune response. Hence, the assay allows for identification of compounds that inhibit virus infection. In addition, because induction of IFN is one of the most common attributes of viruses, the assay is applicable to all the viruses that are able to infect the reporter cell line and induce IFN-? expression.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: October 27, 2015
    Assignees: Baruch S. Blumberg Institute, Drexel University
    Inventors: Andrea Cuconati, Jinhong Chang, Timothy M. Block, Ju-Tao Guo
  • Publication number: 20150265672
    Abstract: The present invention provides small molecule inhibitors of hepatitis B virus (HBV) covalently closed circular (ccc) DNA, which are useful as therapeutics in the management of chronic HBV. The compounds of the invention achieve epigenetic modification of the cccDNA, histone modification and histone deacetylase activity inhibition, thus modulating HBV cccDNA. The present invention further provides methods for modulating HBV cccDNA, for treating or preventing HBV in a subject, and for modulating cccDNA transcription of hepatitis B in a subject.
    Type: Application
    Filed: May 31, 2013
    Publication date: September 24, 2015
    Applicant: DREXEL UNIVERSITY
    Inventors: Ju-Tao GUO, Jinhong CHANG, Timothy M. BLOCK, William A. KINNEY
  • Patent number: 9062007
    Abstract: Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is R is —C(O)—N(R27)(R28) or and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating cognitive or neurodegenerative diseases such as Alzheimer's disease. Also disclosed are pharmaceutical compositions and methods of treating cognitive or neurodegenerative diseases comprising the compounds of formula I in combination with a ?-secretase inhibitor other than those of formula I, an HMG-CoA reductase inhibitor, a gamma-secretase inhibitor, a non-steroidal anti-inflammatory agent, an N-methyl-D-aspartate receptor antagonist, a cholinesterase inhibitor or an anti-amyloid antibody.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: June 23, 2015
    Assignees: Merck Sharp & Dohme Corp., Pharmacopeia Drug Discovery, Inc.
    Inventors: Jared N. Cumming, Ulrich Iserloh, Andrew Stamford, Corey Strickland, Johannes H. Voight, Yusheng Wu, Ying Huang, Yan Xia, Samuel Chackalamannil, Tao Guo, Douglas W. Hobbs, Thuy X. H. Le, Jeffrey H. Lowrie, Kurt W. Saionz, Suresh D. Babu
  • Publication number: 20150124638
    Abstract: A method for virtual carrier aggregation, a base station, and a user equipment are provided. A base station receives measurement capability indication information and indication information indicating a capability of receiving data transmission that are reported by a UE. The base station selects a measurement set for the UE according to the measurement capability indication information, and sends the measurement set to the UE, where the indication information indicating the capability of receiving data transmission includes information of carriers on which the UE supports concurrent receiving of data transmission and the measurement capability indication information includes indication information indicating a capability of the UE for measuring CSI and/or indication information indicating a capability of the UE for measuring RSRP. The base station can flexibly select an activated carrier set for the UE.
    Type: Application
    Filed: January 5, 2015
    Publication date: May 7, 2015
    Inventors: Jingyuan SUN, Liang XIA, Yongxing ZHOU, Xiaotao REN, Mingyu ZHOU, Tao GUO
  • Publication number: 20150105354
    Abstract: Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein W is a bond, —C(?S)—, —S(O)—, —S(O)2—, —C(?O)—, —O—, —C(R6)(R7)—, —N(R5)— or —C(?N(R5))—; X is —O—, —N(R5)— or —C(R6)(R7)—; provided that when X is —O—, U is not —O—, —S(O)—, —S(O)2—, —C(?O)— or —C(?NR5)—; U is a bond, —S(O)—, —S(O)2—, —C(O)—, —O—, —P(O)(OR15)—, —C(?NR5)—, —(C(R6)(R7))b— or —N(R5)—; wherein b is 1 or 2; provided that when W is —S(O)—, —S(O)2—, —O—, or —N(R5)—, U is not —S(O)—, —S(O)2—, —O—, or —N(R5)—; provided that when X is —N(R5)— and W is —S(O)—, —S(O)2—, —O—, or —N(R5)—, then U is not a bond; and R1, R2, R3, R4, R5, R6, and R7 are as defined in the specification; and pharmaceutical compositions comprising the compounds of formula I.
    Type: Application
    Filed: December 18, 2014
    Publication date: April 16, 2015
    Applicants: MERCK SHARP & DOHME CORP., PHARMACOPEIA, LLC
    Inventors: Zhaoning Zhu, Brian McKittrick, Zhong-Yue Sun, Yuanzan C. Ye, Johannes H. Voigt, Corey Strickland, Elizabeth M. Smith, Andrew W. Stamford, William J. Greenlee, Robert D. Mazzola, JR., John Caldwell, Jared N. Cumming, Lingyan Wang, Yusheng Wu, Ulrich Iserloh, Tao Guo, Thuy X.H. Le, Kurt W. Saionz, Suresh D. Babu, Rachael C. Hunter
  • Publication number: 20150089809
    Abstract: A method of engineering a turbomachine airfoil may include providing a master airfoil configuration having a preset outer and inner radius relative to an axis of rotation thereof. The master airfoil configuration may be radially scaled to a custom-sized turbomachine airfoil having an outer radius different than the preset outer radius of the master airfoil configuration, and/or an inner radius different than the preset inner radius of the master airfoil configuration. Tuning a frequency of the custom-sized turbomachine airfoil by changing a parameter of at least one of a part span shroud and a tip shroud may then be performed. Axial scaling may also be performed. The custom-sized turbomachine airfoil may be employed in the turbomachine without performing wheel box testing, and may exhibit substantially similar operational characteristics as the master airfoil configuration.
    Type: Application
    Filed: September 27, 2013
    Publication date: April 2, 2015
    Applicant: General Electric Company
    Inventors: Tao Guo, Michael Ernest Boisclair, Joseph Anthony Cotroneo, Carl Douglas Hofer, Amir Mujezinovic, Vsevolod Yuriyevich Ostrovskiy
  • Publication number: 20150038515
    Abstract: Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.
    Type: Application
    Filed: February 28, 2013
    Publication date: February 5, 2015
    Inventors: Andrea Cuconati, Haitao Guo, Timothy M. Block, Ju-Tao Guo, Xiaodong Xu, Huagang Lu, Dawei Cai